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Abstract: Fraxinus angustifolia leaves and bark are used in traditional medicine against various inflammatory-related pathologies
incumbent to reactive oxygen species (ROS) generation by the NADH oxidase activity of enzymes such as xanthine oxidoreductase
(XOR). This study was designed to investigate the in vitro and in vivo inhibitory activities of this enzyme by Fraxinus angustifolia
extracts. The leaf organic phase of ethyl acetate (LFA) and its bark aqueous counterpart (BFA) showed the strongest anti-NADH oxidase
activity in vitro (IC50 = 38.51 and 42.04 µg mL-1, respectively). They consequently suppressed superoxide generation both enzymatically
(53% and 19%, respectively) and nonenzymatically (34% and 19%, respectively). These results were corroborated in vivo, with high antiNADH oxidase potential of the leaves and bark extracts (75.32% and 51.32%, respectively) concomitant with moderate hypouricemic
activities (36.84% and 38.59%, respectively). Bio-guided fractionation led to the identification, by LC-DAD-MS/MS, of esculin and
calcelarioside in bark and kaempferol glucoside in leaves as the main compounds responsible for the anti-NADH oxidase activity of
XOR. These results plead in favor of the use of F. angustifolia as a source of potentially interesting therapeutic substances.
Key words: Fraxinus angustifolia, NADH oxidase, xanthine oxidoreductase, phenolics, hyperuricemia

1. Introduction
Xanthine oxidase (XO) and xanthine dehydrogenase
(XDH) are interconvertible forms of the same enzyme,
known as xanthine oxidoreductase (XOR). In a
mammalian fresh tissue, XOR exists under the XDH
form, which is NAD-dependent and produces primarily
NADH at the FAD site (Waud and Rajagopalan, 1976;
Hattori, 1989). However, this form is easily converted
to an O2- dependent type (XO) during the procedures of
extraction and purification. Both forms of the enzyme
show NADH oxidase activity, with generation of ROS, but
XDH is somewhat more effective in this respect (Atmani et
al., 2005). In milk, the physiological function of xanthine
oxidase has long been a puzzle, but it turned out to play an
antimicrobial defensive role in the neonatal gut because of
ROS generation (Harrison, 2005). The secretion of milk fat
globules is another useful task of the enzyme in a process
dependent on the enzyme protein rather than on its
enzymic activity (Harrison, 2006). In liver and intestine,
ROS species are directly produced by XOR, with uric acid
as its end product, whereas they are generated secondarily
by XDH, as the enzyme produces primarily the reduced

β-nicotinamide adenine dinucleotide (NADH) (Sanders et
al., 1997; Vorbach et al., 2002). In this case, an increase is
observed in NADH concentration and the generation of
O2- and H2O2 is greatly amplified (Maia et al., 2007). It has
been demonstrated that these ROS species are involved in
the genesis of pathologies such as alcoholic hepatotoxicity
(Teplova et al., 2017) and ischemia-reperfusion injury
(Granger et al., 2001). Additionally, simple upregulation
of XOR activity, irrespective of XDH/XO ratios, could well
be triggered either by hypoxia or by pro-inflammatory
agents, implying a strong link of the enzyme with
inflammation (McCord and Roy, 1982; Cantu-Medellin
and Kelley, 2013). Hyperuricemia could also be generated
by a high XO/XDH activity, causing an accumulation of
uric acid crystals in joints with the ultimate development
of gouty arthritis characterized by an inflammatory
leukocyte response (Haskard and Landis, 2002). Hence,
the inhibition of XO/XDH will contribute to the healing
of this disease.
Numerous studies were directed towards seeking
powerful natural inhibitors of xanthine oxidase
(Berboucha et al., 2009), but much less attention was given
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to the attenuation of its NADH oxidase activity. In this
context, we adopted a novel approach by aiming to study
the inhibitory effect of Fraxinus angustifolia (Oleaceae)
extracts on the NADH oxidase activity of XOR. This
plant was selected mainly because of its antiinflammatory
usage in traditional medicine in Algeria (Beloued, 1998);
in particular, its leaves have antirheumatismal properties
while the bark is indicated against passive hemorrhages,
gout, cholelithiasis and especially against intermittent
fevers (Djerroumi and Nacef, 2004; Kostova and Iossifova,
2007). These medicinal virtues are greatly valorized by rural
populations and may be attributed to the wealth of the plant
in polyphenols such as secoiridoids, phenylpropanoids,
and lignin glucosides (Kong et al., 2002).
Previously, we reported the strong antioxidant potential
of F. angustifolia extracts (Atmani et al., 2009; Ayouni et
al., 2016), including the inhibition of the xanthine oxidase
activity of XOR (Berboucha et al., 2010), as well as their
antiinflammatory (Medjahed et al., 2016) and antidiabetic
(Lowman et al., 1983) activities. To the best of our
knowledge, the ability of F. angustifolia extracts to inhibit
the NADH oxidase activity of XOR has not been studied
thus far. The present study also aimed to identify the
specific molecules responsible for its anti-NADH oxidase
activity in order to validate the traditional use of this plant
in Algeria against inflammation. For that purpose, we
conducted a bio-guided fractionation against the NADH
oxidase activity of XOR.
2. Materials and methods
2.1. Chemicals
The buffer used, ethanol, ethyl acetate, chloroform, and
sodium chloride (NACL) were purchased from Biochem,
Chemopharma (USA). Xanthine oxidase (XO), xanthine,
potassium oxonate, B-Nicotinamide adenine dinucleotide
reduced disodium salt hydrate (NADH), DL-dithiothreitol
(DTT), luteolin, sephadex G-25 gel, and dimethyl
sulfoxide (DMSO) were purchased from Sigma-Aldrich
(France). B-Nicotinamide adenine dinucleotide (NAD+)
and diphenyleneiodonium (DPI) were obtained from Alfa
Aesar (Germany) and acetic acid from Sigma-Aldrich
(Germany). Ferrous sulfate and sodium carboxymethyl
cellulose (CMC), rutin, tannic acid, and vanillic acid
were purchased from Sigma-Aldrich (USA). Uric acid
was obtained from Spinreact (Spain), and cytochrom C
and phanazine methosulfate (PMS) were obtained from
Fluka Biochemica (USA). Nitroblue tetrazolium (NBT),
tris (hydroxymethyl) aminomethane hydrochloride (TrisHCl), and albumin bovine serum (BSA) were obtained
from Biochem Chemopharma (France). Aluminum
chloride anhydrous (AlCl3) was obtained from Biochem
Chemopharma (Canada). EDTA disodium salt was
purchased from Prolabo (EU) and sodium dodecyl sulphate
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(SDS) from Panreact (Spain). Folin-Ciocalteu’s reagent
was obtained from Chim-Oza (France), hydrochloric acid
(HCL) from Organics (Germany), and potassium chloride
(KCl) from Prolabo (France). Sodium carbonate (Na2Co3)
and ferric chloride (FeCl3) were obtained from Biochem
(Montreal, Quebec).
2.2. Plant material
Leaves and barks of F. angustifolia were harvested in
summer from the forest of Azru N’Bechar located in the
Province of Amizour, Department of Bejaia (Northeastern
Algeria), then dried at room temperature and ground to
fine powder (diameter < 63 µm) using an electric mill
(Ika laboratechnik, Staufen, Germany). Plant material
was identified by Professor Hacène Abdelkrim according
to a listed voucher specimen (O/n◦59) in the herbarium
of ENSA (Ecole Nationale Supérieure Agronomique), ElHarrach (Algiers, Algeria).
2.3. Animals
Albino male mice (18–25 g) were obtained from the Center
of Research and Development (CRD SAIDAL, Algiers,
Algeria). They were housed in cages and maintained on
a 12-h light/dark cycle, at 25 °C, with constant humidity.
Animals were handled according to the recommendations
of the International Ethics Committee (Directive of the
European Council 86/609/EC).
2.4. Extraction and fractionation
Extraction of polyphenols was performed using a
previously described procedure (Atmani et al., 2009).
Briefly, the ground powders of leaves and barks were
separately macerated in ethanol (95%) (1/4; w/v) for 24 h
to obtain two crude extracts which were then dried. The
leaf and bark ethanolic extracts were further subjected
to fractionation in ethyl acetate and water (1/3/1; w/v/v),
thereby yielding two separated fractions (ethyl acetate and
aqueous). Two equal amounts of the ethyl acetate fraction
were further fractionated using chloroform and water
(1/3/1; w/v/v). The obtained subfractions were tested for
their potential inhibition of the NADH oxidase activity of
XOR.
2.5. Determination of total phenols, tannins, and flavonoids
The determination of total phenols in the extracts of the
leaves and barks of F. angustifolia was carried out using
standard procedure (Lowman and Box, 1983). The reaction mixture was obtained with 2.5 mL of a solution of
plant extract (0.1 mg mL−1) boiled in methanol, 25 mL
of distilled water, 1.5 mL of sodium carbonate (Na2CO3)
(200 g L−1), and 0.5 mL (1 N) of Folin–Ciocalteu’s reagent.
The mixture was allowed to stand for 60 min at room
temperature, after which the absorbance was recorded
at 750 nm. Total phenols were deduced from a standard
curve and expressed in mg vanillic acid equivalents per
gram of dry plant powder (mg VAE g−1).
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The content of tannins in plant extracts was determined
spectrophotometrically using the bovine serum albumin
(BSA) precipitation method (Hagerman and Butler, 1978).
Solutions of BSA (2 mL) and tannic acid (1 mL) or extract
dissolved in ethanol were mixed. After incubation for 15
min for tannic acid and 24 h for the extract at 4 °C, the
mixtures were centrifuged at 3000 × g for 15 min. The
resulting pellet was dissolved in 4 mL of SDS solution/
TEA (5% triethanolamine added to 1% SDS), followed by
the addition of 1 mL of FeCl3. After 15 min of incubation,
the absorbance was recorded at 510 nm against a blank.
The content in tannins was calculated from the calibration
curve using tannic acid as standard and expressed in mg
tannic acid equivalent/g of extract (mg TAE g−1).
The flavonoid content in plant extracts was determined
by a colorimetric method based on the formation of
ammonium chloride (AlCl3) complex (Maksimović et
al., 2005). The reaction mixture containing 10 mL (1 mg
mL−1) of extract, 2 mL of distilled water, and 5 mL of AlCl3
was incubated for 10 min, after which the absorbance
was measured at 430 nm. The content in flavonoids was
computed from a standard curve using rutin and expressed
in mg rutin equivalent/g of extract (mg RE g−1).
2.6. Bio-guided assays
2.6.1. Preparation of the dehydrogenase form of XOR
Xanthine oxidase was purified from bovine milk according
to a previously described method (Sanders et al., 1997;
Atmani et al., 2005) using centrifugation and column
chromatography. The XDH form was obtained through
reversible reduction of oxidized XO sulfhydryl groups by
incubation with 10 mM dithiothreitol (DTT) for 2 h at 37
°C and then filtered through a small G-25 column.
2.6.2. XDH inhibitory activity
Xanthine dehydrogenase inhibitory activity, using NADH
as substrate, was determined spectrophotometrically at
340 nm by following NADH disappearance under aerobic
conditions every second for 3 min (Atmani et al., 2005).
The reaction mixture contained 1760 µL of phosphate
buffer (20 mM, pH 7.0) and EDTA (0.1 mM), 200 µL of
NADH solution (1 mM) and 20 µL of extract (100 µg mL−1)
dissolved in DMSO or reference compounds (rutin and
esculin). The reaction was initiated by the addition of 20 µL
of XDH (1 U) solution. Diphenyleneiodonium (DPI) was
also tested in the same conditions. The inhibitory activity
of XDH was calculated as follows: % inhibition = [1− [Δ
at / Δ Ac]] × 100, where ΔAt and ΔAc are the variations
in absorbance of the test solution with and without the
extract or reference drug, respectively.
2.6.3. Lineweaver–Burk plots
Extracts with high XDH-inhibitory activity were selected
for performing the Lineweaver–Burk plot analysis in
order to determine their mode of inhibition. This kinetic

study was carried out in the absence or presence of either
extracts or rutin with various concentrations of NADH
(25, 50, 75, 100, and 125 µM). Kinetic parameters (Vmax
and Km) were also determined.
2.6.4. Superoxide anion scavenging activity
The scavenging activity towards superoxide anion radical
was determined according to the method of Liu et al.
(1997). Superoxide anion was generated nonenzymatically
by the phenazinemethosulfate-nicotinamide adenine
dinucleotide (PMS-NADH) system based on the reduction
of nitroblue tetrazolium (NBT). Superoxide anion was
generated in 3 mL of Tris-HCl buffer (100 mM, pH 7.4)
containing 0.75 mL of NBT (300 μM), 0.75 mL of NADH
(936 μM), and 0.3 mL of extract (100 μg mL−1). The
reaction was initiated by the addition of 0.75 mL of PMS
(120 μM) to the mixture. After 5 min of incubation at room
temperature, the absorbance was measured at 560 nm.
The superoxide anion scavenging activity was calculated
according to the following equation: % scavenging = [(A₀
− A₁) / A₀ × 100], where A0 and A1 are the absorbencies
of the solution in the absence and presence of the extract,
respectively.
2.6.5. Superoxide anion generation by NADH-xanthine
dehydrogenase activity
Superoxide production was determined in terms of the
reduction of cytochrome C (25 µM) and calculated by using
an absorption coefficient of 21 mM−1 Cm−1, with NADH
as the reducing substrate. The reaction mixture in a total
volume of 1 mL contained 50 mM potassium phosphate
buffer (pH 7.4), NADH (100 µM), and cytochrome C (25
µM). A concentration of 100 µg mL−1 of plant extract was
added into the mixture. The reaction was initiated by the
addition of XDH (25 mU mL−1) and monitored at 550 nm
for 10 min.
2.7. UHPLC-MS analysis
LC–MS analyses were performed on an UHPLC 1290
series apparatus from Agilent Technologies (Santa Clara,
CA, USA) connected to an Esquire LC-ESI-MS/MS from
Bruker Daltonics (Bremen, Germany). The column used
was a C18 reversed-phase ZORBAX Eclipse Plus column
from Agilent Technologies (2.1 × 100 mm, 1.8 µm, 10
cm). A solution of 2 mg mL−1 of F. angustifolia extract was
prepared in methanol/water (50/50), shaken vigorously,
filtered, and injected directly into the HPLC system. The
flow of solvent was 0.4 mL min−1 with an injection volume
of 1 µL (solvent system of 0.1% (v/v) formic acid-water
(A), 0.1% (v/v) formic acid-acetonitrile (ACN) (B)). The
separation was conducted using the following gradient:
solvent B 0 min at 10%, 1.7 min at 10%, 3.4 min at 20%,
5.1 min at 30%, 6.8 min at 30%, 8.5 min at 35%, 11.9 min
at 60%, 15.3 min at 100%, 17.0 min at 100%, and 17.3 min
at 10%. The absorbance was measured at two wavelengths
as 280 and 360 nm.
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2.7.1. Preparative HPLC chromatography
Pure compounds were obtained by preparative HPLC on a
Smartline system from Varian TM (Smartline, Pump 1000,
Manager 5000, Detector UV K-2600, Berlin, Germany).
The chromatographic parameters were optimized for
the best resolution and sensitivity. The extracts were
prepared at a concentration of 200 mg mL−1 in methanol/
water (50/50). Peak shape analyses were performed
using a column of Kinetex 5VXB-C18 (150 × 21.2 mm)
with a gradient of acidified water (0.1% TFA; solvent A)/
acidified ACN (0.1% TFA; solvent B); the solvent flow rate
was 20 mL min−1 for an injection volume of 250 µL. The
separation was conducted using the following gradient:
solvent B 0 min at 20%, 5 min at 20%, 30 min at 40%, 31
min at 100%, 37 min at 100%, and 45 min at 20%.
2.8. Hyperuricemia model in mice
The experimental animal model of hyperuricemia was
established using a uricase inhibitor (potassium oxonate,
250 mg kg−1 b.w), as previously described (Wang et al., 2010).
Oxonate, the extracts of plant, and diphenyleneiodonium
(DPI) as positive reference were dissolved or dispersed in
CMC (0.8%). Food, but not water, was withdrawn from
the animals 1 h prior to drug or extract administration.
2.8.1. Drug administration
Mice were divided into categories I and II composed
respectively of normal and hyperuricemic mice. Each
category was divided into eight groups (n = 6). Briefly,
category II mice were injected intraperitoneally with
potassium oxonate (PO) (250 mg kg−1) 1 h before the final
tested drug administration for three consecutive days to
increase the serum urate levels. The negative control group
(GI) received vehicle (CMC at 0.8%) while hyperuricemic
control group (GII) received PO. The positive control
group (GIII), which included normal or hyperuricemic
mice, received an oral dose of 10 mg kg−1 b.w. of DPI.
Groups IV and V received 100 and 200 mg kg-1 b.w. of F.
angustifolia leaf ethyl acetate extract (LFA), or 100 and 200
mg kg−1 bark aqueous ethyl acetate extract (BFA). Groups
VI, VII, and VIII received 10 mg kg−1 of rutin, luteolin,
and esculin, respectively. The animals were sacrificed and
the whole blood samples were collected 1 h after the final
drug administration. The serum obtained after blood
centrifugation (5000 rpm for 10 min) was stored at −20 °C
until use. Determination of uric acid levels was achieved
using standard diagnostic kits (Spinreact).
2.8.2. Assay of xanthine/NADH XOR activity
After the sacrifice, the liver of animals was rapidly excised,
washed in saline (0.9%), and homogenized in 5 volumes of
80 mM sodium pyrophosphate buffer (pH 7.4) at 4 °C. The
homogenate was centrifuged at 5000 × g for 10 min and
the resulting supernatant fraction was further centrifuged
at 5000 × g for 15 min at 4 °C. The final supernatant was
stored at −80 °C.
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The activity of XDH was assayed by monitoring uric
acid formation using a spectrophotometric method
described previously (Kong et al., 2002). Briefly, 100 µL
of supernatant was added to 50 mM phosphate buffer
(pH 7.5), 200 µM NAD+, and 1 mM potassium oxonate to
prevent oxidation of uric acid to allantoin, in a final reaction
volume of 5 mL. After incubation for 15 min at 37 °C, the
reaction was initiated by the addition of 50 mM xanthine.
Ten minutes later, the reaction was stopped by the addition
of 0.5 mL HCl (0.58 M). Absorbance was recorded at 295
nm for xanthine oxidase activity and at 340 nm for NADH
oxidase activity following centrifugation (5000 × g for 5
min). XDH activity was expressed as nanomoles uric acid
produced per min per mg protein (nmol UA min−1 mg−1
prot) based on a calibration curve for uric acid. The total
protein concentration of the homogenates was determined
by the Bradford method (1976) using bovine serum
albumin as the standard.
2.9. Statistical analysis
The data were expressed as mean ± SD of triplicate assays
for in vitro assays and mean ± SEM for in vivo assays.
Statistical analysis was carried out using the Graph Pad
Prism software (one-way analysis of variance ANOVA).
IC50 values were calculated using the OriginPro7.5
software. The differences were considered significant at *P
< 0.05, **P < 0.01, and ***P < 0.001.
3. Results
3.1. Solvent extraction yields and quantification of total
phenols, flavonoids, and tannins
Extraction yields from the raw plant material showed a
higher percentage for the crude extract of leaves (17%),
compared to its bark counterpart (5%) (Table1). Moreover,
a higher yield in leaves was obtained in ethyl acetate phase
(11%) while bark constituents were more soluble in the
aqueous phase of ethyl acetate (3%).
The quantification of total phenols indicated that the
crude ethanolic leaf extract contained significantly more
total phenols (535 mg VAE g−1) than the corresponding
bark extract (83 mg VAE g−1) (Table 1). The amount of total
phenols ranged from 326 to 1143 mg VAE g−1 extract for
leaves, the highest being that of the aqueous chloroform
extract phase (1144 mg VAE g−1 extract). On the other
hand, lower ranges were noticed for bark extracts (25 to
189 mg VAE g−1), the most prominent being that of the
organic ethyl acetate phase (189 mg VAE g−1 extract).
Concerning flavonoids, higher amounts were found in
extracts of bark in contrast to leaves (Table 1), except for
the ethyl acetate extract phase where comparable amounts
were observed in both parts of the plant (46 ± 1 and 43 ± 1
mg RE g-1 for leaves and bark, respectively).
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Table 1. Extraction yields, total phenols, flavonoids, tannins, and inhibition of NADH oxidase activity of F. angustifolia extracts from
leaves and bark obtained by sequential extraction.
Total phenols
(mg VAE g−1)

Yield (%)

Flavonoids
(mg RE g−1)

Tannins
(mg TAE g−1)

Inhibition of NADH
activity (%)

Leaves

536 ± 1

83 ± 1

31 ± 1

63 ± 2

159 ± 3

394 ± 49

73***

85***

Ethyl acetate

11

0.7

27 ± 1

189 ± 1

46 ± 1

43 ± 1

327 ± 8

66 ± 5

87

86***

Aqueous ethyl acetate

6

2.85

529 ± 1

68 ± 1

31 ± 1

39 ± 2

66 ± 1

23 ± 23

63***

91*

Chloroform

10

0.5

389 ± 1

170 ± 1

35 ± 1

55 ± 2

313 ± 6

877 ± 17

80

80***

Aqueous chloroform

0.3

0.05

1144 ± 1

25 ± 1

30 ± 1

62 ± 2

57 ± 5

45 ± 44

68***

73***

*

Bark

Bark

5

Esculin

Leaves

Leaves

17

Bark

Bark

Leaves

Ethanolic

Bark

Leaves

Extracts

86***

Data are presented as means ± SD, n = 3. One-way ANOVA followed by Dunnett multiple comparison test was used for statistical
significance. *P < 0.05; **P < 0.01; ***P < 0.001 when compared with normal control values.
ANOVA = Analysis of variance; SD = standard deviation; VAE = Vanillic acid equivalent per gram of extract;
TAE = Tannic acid equivalent per gram of extract; RE = Rutin equivalent per gram of extract.

3.2. Inhibition of NADH oxidase activity of xanthine dehydrogenase (XDH)
The results illustrated in Table 1 indicated that the ethyl
acetate extract of leaves (LFA) and aqueous ethyl acetate
of bark (BFA) were the most potent against the NADH
oxidase activity of XDH (86%; IC50 = 38.51 µg mL−1, 91%;
IC50 = 42.04 µg mL−1, respectively), with higher efficiency
for leaf extract (P < 0.05). Rutin and esculin suppressed the
enzyme as efficiently as LFA and BFA (89%, IC50 = 32.20
µg mL−1, 86.42%, IC50 = 39.26 µg mL−1) but less than DPI
(93%, IC50 = 28.24 µg mL−1).
3.3. Correlation analysis
In order to establish a relationship between the amounts
of total polyphenols, flavonoids, and tannins and the
NADH-inhibitory activity of XOR, a correlation study
was conducted. For the most active extract of leaves
(LFA), strong correlations were observed between the
inhibition of NADH oxidase activity and total phenols (P
< 0.001, R2 = 0.92), flavonoids (P < 0.01, R2 = 0.73), and
tannins (P < 0.001, R2 = 0.78) (Figures S6, S8, S10). On
the other hand, bark extract (BFA) showed an important
correlation between NADH oxidase inhibitory activity
and total phenols (R2 = 0.62), but more moderate regarding
flavonoids (P < 0.01, R2 = 0.50) and tannins (P < 0.001, R2 =
0.44) (Figures S7, S9, S11).
The Lineweaver–Burk plots in the presence of 100
µg mL−1 of LFA or BFA (Figure 1) suggest a mixed-type
inhibition. The Km value for leaves was lower than that of
bark (Table 2), the latter being comparable to that of rutin
(Km = 50 µM). On the other hand, esculin had the lowest
Km value (16.66 µM).

3.4. Superoxide anion scavenging activity
The results illustrated in Figure 2 indicated that both LFA
and BFA showed a moderate effect (34% and 19% at 100 µg
mL-1, respectively) on the neutralization of the superoxide
radical using the PMS-NADH system, lower than their
activity in the enzyme (NADH-XDH) system (P < 0.001)
(53.69% and 19.17%, respectively) (Table 3).
Rutin, used as the reference molecule, showed a similar
inhibition percentage in the first system of 41% (Figure 2),
slightly lower than that of the second (44.1%) (Table 3).
3.5. HPLC analysis
HPLC analysis revealed a diverse range of phenolic
compounds including lignans, secoiridoids, and
flavonoids, with a higher number in bark rather than in
leaves (Tables 4 and 5). Data also indicate that some phenol
constituents such as verbascoside, calcelarioside, and
ligstroside, characteristically found in all Fraxinus species,
were shared by the parent crude extract and its derivatives.
Indeed, our results (Table 5) revealed that the bark of
F. angustifolia contained high amounts of both esculin
and fraxin (92 and 213 mg eq quercetin kg−1 extract,
respectively). On the other hand, the leaves of F. angustifolia
were found to be an important source of Kaempferol
rutinoside and quercetin glucoside (133.95 and 207.28 mg
eq quercetin kg−1 extract).
3.6. Characterization and identification of bioactive
compounds
Seven (1–7) fractions were obtained by preparative HPLC
chromatography from LFA (Figures S1 and S2) that
exhibited respective inhibition rates against the NADH
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Figure 1. Lineweaver Burk representation of the inhibition of the NADH oxidase activity of XDH by ethyl acetate leaves (LFA) (A)
and aqueous ethyl acetate bark (BFA) (B) extracts of F. angustifolia, rutin (C) and esculin (D).

Table 2. Kinetic parameters of ethyl acetate leaves and aqueous ethyl acetate bark extracts
of F. angustifolia on NADH oxidase activity.
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Km (µM)

Km’ (µM)

Vmax (Δabs S−1)

Vmax’ (Δabs S−1)

Leaves

40

152

7.7

2.0

Bark

47

133

10

3.6

Rutin

50

8

0.2

0.03

Esculin

16.66

49.98

4

1.33
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(%) Scave nging capacit y

100
LFA
80

BFA
Rutin

60
40
20
0

Concentration (µg/ml)

Figure 2. Scavenging activity of superoxide anion generated by
PMS-NADH by F. angustifolia extracts, and rutin.

oxidase activity of XDH from 0 to 84.20 ± 0.35 (Figure
3A), while the BFA was fractionated to eleven molecules
(1–11) (Figures S3 and S4), showing inhibition rates from
0 to 84.74 ± 1.60 (Figure 3B), respectively.

3.7. Antihyperuricemic effect of F. angustifolia extracts
in potassium oxonate-induced hyperuricemic mice
3.7.1. Uric acid levels
For the uric acid assay, the intraperitoneal injection of
PO at a dose of 250 mg kg−1 significantly (P < 0.05) raised
the mean serum uric acid levels from 3.16 mg dL−1 (Table
6) to 4.67 mg dL−1 (Table 7). On the other hand, in nonhyperuricemic mice, as illustrated in Table 6, treatment
with LFA and BFA (100 mg kg−1) reduced the serum uric
acid levels equally and considerably by 40% and 42%,
respectively, which is significantly lower than that of the
reference drug, DPI (89.9%), in agreement with in vitro
results.
In contrast, in hyperuricemic mice (Table 7), the
reduction in uric acid levels was more pronounced but
followed the same trend with, once again, comparable
efficiency for the two extracts (56.95% and 57.38% for LFA
and BFA, respectively). A remarkable drop of the amount
of blood urate was also noticed for DPI (78.84%), which
confirms its hypouricemic effect. Esculin reduced the
serum uric acid levels by 84.91% and 78.94% in normal
and hyperuricemic mice, respectively (Tables 6 and 7).

Table 3. Superoxide production and inhibition of superoxide anion generated by NADH –
XDH system by F. angustifolia extracts.
Extracts (100 µg mL−1)

Superoxide production
(mM) ± SD

Superoxide inhibition
(%) ± SD

Ethyl acetate of leaves

0.016 ± 0.02

53.69 ± 0.07

Aqueous ethyl acetate of bark

0.028 ± 0.07

19.17 ± 0.02

Rutin

0.019 ± 0.001

44.1 ± 0.001

Table 4. Identification of phenolic compounds in ethyl acetate leaves extract of F. angustifolia using retention times, LC-MS and UV data.

Peak

RT
(min)

UV max
(nm)

m/z
[M-H−]

MS/MS−

1

1.5

280

153

2

4.7

360-260

3

4.9

4

5.1

Aires

(mg eq quercetin
kg−1 extract)

Identification

123

11.59

154.12 ± 3.5

Hydroxytyrosol (Niemetz and Gross, 2001)

609

301-208-146273-343

45.49

253.40 ± 2.5

Quercetin rutinoside
(Niemetz and Gross, 2001)

340-285
280

463
623

301-162
461-162

29.74

207.28 ± 2.5

Quercetin glucoside
(Niemetz and Gross, 2001)
Verbascoside (Sun et al., 2015)

340

593

285-162

4.7

133.9 ± 1.06

Kaempferol
rutinoside (Eyles et al., 2007)

5

5.3

340-360

447

285-447

1.25

123.8 ± 0.68

Kaempferol glucoside (Eyles et al., 2007)

6

5.8

280

539

275-307377-232

143.14

539.3 ± 19.2

Oleuropein (Sun et al., 2015)

7

6.3

280

523

291-223

9.21

147.1 ± 1.02

Ligstroside (Sun et al., 2015)
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Table 5. Identification of phenolic compounds in aqueous ethyl acetate of bark extract of F. angustifolia using retention times, LC-MS
and UV data.

Peak

RT
(min)

UV max
(nm)

[M-H−]

MS/MS−

1

1.4

285

375

152-122-167

62.12

(mg eq
quercetin kg−1
extract)
78.5 ± 7.37

2

2.2

340

339

177

80.97

92.8 ± 3.33

Esculin (Frison-Norrie and Sporns, 2002)

3

2.7

265

417

161-368-207

174.39

163.9 ± 14.9

Unknown

4

3.4

285-340

369

206-162

263.07

231.4 ± 10.2

Fraxin (Frison-Norrie and Sporns, 2002)

5

3.8

330

429

208-162-221383-369-206

29.94

54.02 ± 4.29

Unknown

6

3.8

285-340

429

206-177383-223

41.48

62.8 ± 5.09

Unknown

7

4.5

280

535

373

41.83

63.07 ± 4.5

Pinoresinol
(Frison-Norrie and Sporns, 2002)

8

4.6

285-328

477

161-315

60.63

77.3 ± 14.7

Calcelarioside
(Frison-Norrie and Sporns, 2002)

9

4.9

280-330

623

461-162

49.30

68.75 ± 9.1

Verbascoside (Sun et al., 2015)

10

5

285-328

477

133-161-315

186.38

173.08 ± 1.3

Calcelarioside
(Frison-Norrie and Sporns, 2002)

11

5.1

280-328

685

291-361-523

91.73

101.04 ± 6.7

Ligstroside hexoside (Sanz et al., 2012)

m/z

Aires

80

80
inhibition (%)

100

inhibition (%)

100

60
40
20
0

Identification
Unknown

60
40
20

1

2

3

4
Fractions

5

6

7
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1

2

3

4

5

6
7
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Figure 3. Inhibition of the NADH oxidase activity of XDH by HPLC fractions obtained from ethyl acetate leaves (LFA) (A), aqueous
ethyl acetate bark (BFA) (B) extracts of F. angustifolia.

3.7.2. XDH and NADH oxidase assays in vivo
In order to perform a detailed investigation of the
hypouricemic effect of F. angustifolia extracts, liver
XDH activities in the presence of xanthine and NADH
in normal and hyperuricemic mice were calculated
from a calibration curve using uric acid (Figure S5). The
results (Table 7) revealed that LFA and BFA (100 mg
kg−1) inhibited liver XDH activity effectively and equally
(38.6% and 36.8%, respectively) in hyperuricemic mice
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treated with OP. On the other hand, even though the
inhibitory values of the same extracts in normal mice
against XDH turned out to be weak, with 21.7% and 33.5%
of inhibition, respectively, at the same concentration,
they exerted a good NADH oxidase inhibitory activity
(72.92% and 59.88%, respectively) in normal (Table 6)
and hyperuricemic (75.32% and 51.32%, respectively)
mice (Table 7). Moreover, the administration of DPI led to
better liver XDH inhibitory activity than the extracts with
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GI
GII
GIII
GIV
GV
GVI
GVII
GVIII

Negative control
Hyper uricemic control
DPI
LFA
LFA
BFA
BFA
Rutin
Luteolin
Esculin

10
100
200
100
200
10
10
10

88.89
40.18
34.49
42.08
30.69
84.91

3.1 ± 0.03***
4.6 ± 0.04***
0.35 ± 0.003
1.9 ± 0.04***
2.07 ± 0.03***
1.8 ± 0.01***
2.19 ± 0.01***
0.54 ± 0.01

0.91 ± 0.14
1.32 ± 0.07
2.05 ± 0.06***
1.79 ± 0.01***
1.97 ± 0.28***
1.83 ± 0.03***
1.26 ± 0.06
1.30 ± 0.08

50.26
21.77
17.52
33.52
11.10
25.13
29.21
41.29

4.77 ± 0.002
3.02 ± 0.1***
4 ± 0.14***
6.3 ± 0.002***
5.52 ± 0.04***
3.95 ± 0.09***
5.07 ± 0.06***
6.01 ± 0.07***

NADH oxidase
Inhibition (%)

NADH oxidase (U
mg-1 protein)

XDH Inhibition (%)

XDH (nmol uric acid
mg−1 protein)

Serum uric acid
levels (mg dL−1)

Uric acid reduction
(%)

Dose (mg kg−1 b.w.)

Treatment

Groups

Table 6. Effects of F. angustifolia extracts and DPI on serum uric acid levels, Xanthine dehydrogenase and on NADH oxidase activities
in normal mice.

69.57
72.92
64.23
59.88
59.06
67.74
48.66
54.36

Data are presented as means ± SEM, n = 6. One-way ANOVA followed by Dunnett multiple comparison test was used for statistical
significance. *P < 0.05; **P < 0.01; ***P < 0.001 when compared with normal control values.
LFA = F. angustifolia leaf ethyl acetate extract; BFA= F. angustifolia bark aqueous ethyl acetate extract; ANOVA = analysis of variance;
SEM = standard error of the mean.
Animal groups are as follows: Group I, negative control; Group II, hyperuricemic control; Group III, diphenyliodonium (DPI) treated
group; Group IV, 100 mg kg−1 b.w. F. angustifolia LFA-treated group; 200 mg kg−1 b.w. F. angustifolia LFA extract-treated group; Group
V, 100 mg kg−1 b.w. F. angustifolia BFA extract-treated group; 200 mg kg−1 b.w. F. angustifolia BFA-treated group; Group VI, 10 mg kg−1
rutin-treated group; Group VII, 10 mg kg−1 luteolin-treated group; Group VIII, 10 mg kg−1 Esculin-treated group.

comparable inhibition in normal and hyperuricemic mice
(50% and 48% respectively). Concerning anti-NADH
oxidase activity, LFA outperformed DPI, rutin, and esculin
(69.57, 67.74 and 54.36%, respectively) in normal (Table 6)
and hyperuricemic (72.12, 59.73 and 68.27%, respectively)
(Table 7) mice.
The suppression of the orally administered rutin
and esculin (10 mg kg-1), two essential components of
F. angustifolia, of XDH activity in normal mice was by
25.13% and 41.29%, respectively, compared to oxonatepretreated mice (40.43% and 49.98%, respectively) (Tables
6 and 7, respectively).
4. Discussion
The extraction process is a key step that aims to draw
out the maximal amount of compounds from the plant.
The highest extraction percentages were recorded in
the crude extracts of both leaves and bark, with leaves
surpassing bark. The results also indicated that the yields
of extraction varied considerably between the aqueous and
organic phases as a function of the solubility of the plant
constituents in the solvent used, as previously observed
for other natural extracts (Naczk and Shahidi, 2004). The

organic phase of ethyl acetate of leaves (LFA) marked
a high percentage of extraction relatively to the other
phases. Moreover, tannins were more abundant in organic
phases than in the aqueous ones, implying that they are
condensed rather than hydrolysable tannins.
In an attempt to establish a potential relationship
between NADH oxidase inhibitory activity and the
amount of phenolic compounds in various extracts tested,
total phenols, flavonoids, and tannins were determined.
Substantial amounts of phenolic compounds were found
in all leaf extracts compared to their bark counterparts,
which witnesses that F. angustifolia leaves constitute a rich
source of bioactive molecules. Moreover, a recent study
conducted on F. angustifolia native of Béja (17.55 and 24.84
mg GEA g-1 , respectively) and Nefza (21.86 and 22.85 mg
GEA g-1, respectively), two regions in Tunisia, revealed a
lower proportion of phenols in leaves compared to bark
(Touhami et al., 2017), compared to LFA and BFA extracts
used in the present study. This variation is generally
attributed to climatic changes and geographic localization.
Higher phenols in the aqueous phase of chloroform
derived from leaves reveal a higher amount of constituents
with OH groups in this extract (Veličković et al., 2007). On
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Negative control

GII

Hyper uricemic control

GIII

DPI

10

LFA
LFA

3.16 ± 0.03***

-

-

-

4.67 ± 0.04

-

-

78.84

0.56 ± 0.05

1.54 ± 0.11

48.35

2.69 ± 0.03

100

56.95

2.01 ± 0.04

2.02 ± 0.24

200

57.10

2 ± 0.01***

2.87 ± 0.013*

BFA

100

57.38

1.9 ± 0.001

BFA

200

53.10

2.32 ± 0.03***

GVI

Rutin

10

-

GVII

Luteolin

10

-

GVIII

Esculin

10

78.94

GV

***

NADH oxidase
Inhibition (%)

NADH oxidase
(U mg−1 protein)

XDH
Inhibition (%)

-

GIV

-

Serum uric acid
levels (mg dL−1)

Uric acid
reduction (%)

Dose
(mg kg−1 b.w.)

Treatment

Groups
GI

XDH (nmol uric
acid mg−1 protein)

Table 7. Effect of F. angustifolia extracts and DPI on serum uric acid levels, xanthine dehydrogenase, and on NADH oxidase activities in
mice pretreated with the uricase inhibitor, potassium oxonate.

72.12

38.59

***

1.9 ± 0.002

75.43

11.86

3.25 ± 0.08***

60.34

1.85 ± 0,78

36.84

4.68 ± 0.08

51.32

2.99 ± 0.13*

23.21

6.05 ± 0.1***

49.2

-

1.49 ± 0.046

40.43

4.03 ± 0.1

59.73

-

2.97 ± 0.048*

30.75

4.46 ± 0.05***

52.69

0.78 ± 0.02

1.10 ± 0.03

49.98

3.18 ± 0.03

68.27

***

***

***

***

***

Data are presented as means ± SD, n = 3. One-way ANOVA followed by Dunnett multiple comparison test was used for statistical
significance. *P < 0.05; **P < 0.01; ***P < 0.001 when compared with normal control values.
LFA = F. angustifolia leaf ethyl acetate extract; BFA = F. angustifolia bark aqueous ethyl acetate extract.
Animal groups are as follows: Group I, negative control; Group II, hyperuricemic control; Group III, diphenyliodonium (DPI) treated
group; Group IV, 100 mg kg−1 b.w. F. angustifolia LFA-treated group; 200 mg kg−1 b.w. F. angustifolia LFA extract-treated group; Group V,
100 mg kg−1 b.w. F. angustifolia BFA extract-treated group; 200 mg kg−1 b.w. F. angustifolia BFA-treated group; Group VI, mg kg−1 rutintreated group; and Group VII, 10 mg kg−1 luteolin-treated group; Group VIII, 10 mg kg−1 Esculin-treated group.

the other hand, the highest amount of flavonoids in the
ethyl acetate phase of leaves is in agreement with previous
findings (Atmani et al., 2009; Berboucha et al., 2010) and
reflects the higher extraction yield of this phase. In fact, a
positive correlation between total phenols and inhibition
performance of LFA and BFA (Table 1) emphasizes the
impact of quantity over performance. On the other hand,
a lower correlation was found between the content of
flavonoids and tannins and the inhibition of the NADH
oxidase activity of XDH.
As a potential source of ROS, the NADH oxidase
activity of XDH is considered to be responsible for
producing superoxide faster (Sanders et al., 1997) and
more (Maia et al., 2007) than its XO counterpart, which
highlights the importance of its inhibition. However, this
activity has been little studied, which motivated the present
investigation. Our interest focused on the attenuation of
NADH oxidase by extracts of F. angustifolia to assess their
capacity to prevent oxidative stress-related pathologies.
Moreover, the traditional use of F. angustifolia against
gout drew our attention to their possible involvement in
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XOR inhibition. LFA was more potent against the NADH
oxidase activity of XDH than BFA, but both remained less
efficient than DPI. A previous report (Atmani et al., 2005)
indicated that DPI (1 µM) strongly inhibited the NADH
oxidase activity of caprine milk XOR (97.3%), a result
narrowly close to our findings concerning this molecule.
The specific structure of DPI, an aromatic heterocyclic
cation composed of 2 benzene rings fused with an
iodolium ion, seems to be ideal for the inhibitory activity
of the FAD site of the enzyme.
In an attempt to gain more insight into the mechanism
of action of F. angustifolia extracts, NADH oxidaseinhibitory activity of XDH was tested using various
concentrations of NADH in the absence and presence of
selected extracts and standard. A mixed-type inhibition
was recorded which is a predictable outcome pertaining
to the fact that an extract is not a pure molecule but rather
a mixture of components exerting different actions on
the enzyme, some being competitive inhibitors, others
noncompetitive. On the other hand, rutin, an important
constituent of leaves (Table 2), showed uncompetitive
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inhibitory activity (Figure 1), whose action could be altered
by other active components of the extract, thus leading to a
mixed-type inhibition for that extract. The same applies to
esculin, which showed a noncompetitive mixed inhibitory
activity (Figure 1).
The efficiency of the extracts on the repression of XDH
could be explained by the nature of their constituents,
which could exert an inhibition on the active sites of the
two forms of the enzyme, but more importantly on the
FAD site where substrates of XDH favorably act. In fact,
the conversion of XO to XDH results in conformational
changes affecting mostly the FAD site (Enroth et al.,
2000). Bindoli et al. (1985) revealed that different types
of inhibition of the oxidase (competitive type) and the
dehydrogenase (mixed-type) appear to depend on the
redox state of the sulfhydryl groups of xanthine-oxidizing
enzyme. This means that in the dehydrogenase form,
reduction with DTT favors a conformational modification
of the enzyme (more dithiols over the disulfides), hence
affecting its kinetic parameters. A previous study on XO/
xanthine inhibition by F. angustifolia extracts (Berboucha et
al., 2010) demonstrated that the ethyl acetate leaves extract
and its aqueous counterpart of bark exerted less inhibition
on XO, compared to XDH, in close agreement with
Bindoli’s observations. In the same context, allopurinol (5
µM), oxypurinol (5 µM), and amflutizole (1 µM), which
are drugs often used to combat gout and arthritis and
reputed to be strong inhibitors of xanthine oxidase activity
of XOR, poorly suppressed the NADH oxidase activity of
XOR (Atmani et al., 2005), which confirms that the two
forms of the enzyme have two different sites of inhibition.
The comparison of Km values gives an indication of
the affinity between substrate and inhibitor of the enzyme
(Dixon, 1972). The lower the Km, the higher the affinity
of inhibitor to substrate-enzyme complex. Indeed, the
Km values of the leaves and bark extracts (Table 2) are in
satisfactory agreement with their high inhibitory activity
obtained against the NADH oxidase activity of XDH, while
the Km value for esculin was the lowest, demonstrating its
stronger affinity to substrate-enzyme complex.
It has long been recognized that naturally occurring
substances in higher plants were endowed with
antioxidant activity (Atmani et al., 2009). The most
prominent one, flavonoids, are reputed to be powerful
free radical scavengers. Superoxide anion is produced
by NADH oxidase activity (Sanders et al., 1997; Atmani
et al., 2005) and can be a source of many deleterious free
radicals such as OH. (Doroshow, 1983). The potential
elimination of this radical can occur through simple
scavenging (nonenzymatically) or by inhibition of the
NADH oxidase activity of XOR. Both methods were
assessed and concluded to have the better performance
of the extracts in the enzymatic system, which is in

accordance with their high anti-NADH oxidase activity
of XDH, as shown above. Since the nonenzymatic
system evaluates solely the scavenging activity of the
extracts while the enzymatic system is a result of both
scavenging and enzymatic inhibition, we can infer that the
suppression of the generation of superoxide radical by the
NADH oxidase activity of XDH has overridden that of its
scavenging potential. Our findings also confirm a higher
potential for LFA to suppress the production of superoxide
enzymatically, which is in agreement with its higher
NADH oxidase inhibitory activity. These results are highly
relevant in relation to the fact that superoxide anion is
implicated in endothelial dysfunction and therefore in the
genesis of cardiovascular disease (Hamilton et al., 2001).
This was demonstrated for DPI, which, as it suppressed
NADH oxidase activity strongly thereby eliminating
superoxide anion, led to the improvement of endothelial
function (Hamilton et al., 2001). On the other hand,
the results obtained for rutin reflect its NADH oxidase
inhibition potential (Figure 2), but also reveal a high
scavenging activity, in contrast to those of extracts.
In order to characterize the bioactive compounds
responsible for the anti-NADH oxidase activity, the HPLC
analysis was carried out. The characterization of all the
extracts was based on the comparison of UV data, mass
spectrometry (MS), and MS fragmentation behavior with
the published data standards. We focused our attention on
the most active extracts, namely LFA and BFA, in order to
identify their most active constituents. It should be noted
that ligstroside hexoside was identified for the first time
in the composition of F. angustifolia bark while previous
investigations detected this compound in Fraxinus
excelsior (Iossifova et al., 1997). Furthermore, we noticed
the occurrence of rutin in leaves and its absence in bark
(Table S1 and S2), as previously reported (Ayouni et al.,
2016; Medjahed et al., 2016). Our data have also confirmed
a high proportion of hydroxycoumarin glucoside (esculin)
in both leaves and bark of F. angustifolia, an compound
which is considered to be a characteristic feature of
Fraxinus species (Jenson et al., 2002; Perez et al., 2005).
The coumarin glucosides esculin and fraxin occur in
almost all Fraxinus species. However, their ratio varies
depending on the different plant sources. For example,
esculin predominates in Fraxinus ornus bark (Kong et
al., 2002). The presence of Kaempferol rutinoside and
quercetin glucoside in F. angustifolia leaves was confirmed
by a metabolomic study (Ayouni et al., 2016), which showed
that flavonoid glucosides (Kaempferol 3-O-rutinoside,
quercetin 3-O-glucoside, and rutin) were revealed to be
highly involved in the antioxidant potential of leaves.
LFA and BFA, being the most active against NADH
oxidase activity, were further fractionated by preparative
chromatography. A higher number of compounds in bark
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reassert the wider diversity of polyphenols in that part of
the plant rather than leaf extracts. Moreover, more flavonol
glycosides such as rutinoside derivatives of quercetin and
kaempferol were detected in ethyl acetate extract of leaves
rather than in the corresponding aqueous phase of ethyl
acetate of bark. Previous investigations reported that
flavanols having a 7-hydroxyl group such as quercetin are
included among the most effective inhibitors of XDH (Zhu
et al., 2004), which is in line with the higher inhibition
potential of leaf extracts.
In fact, the highest inhibition rate for leaves was
exhibited by fraction 4 containing kaempferol rutinoside
(Table 4). Esculin, on the other hand, was identified in
the most potent fraction 2 of bark, followed by fraction
10 containing calcelarioside (Table 5). These compounds
were not found in their highest proportion in the extracts,
in contrast to oleuropein and fraxin, which were found
in considerable amounts in leaves and bark, respectively
(Tables 4 and 5). These observations highlight the fact that
the quantity of the constituents may not be as important
as their structure in their inhibition potential against the
NADH oxidase of XDH. This is in close agreement with
the low correlation of flavonoids with activity. Indeed,
if the structural features of kaempferol rutinoside and
esculin are examined, it can be noticed that they share
a high number of OH groups, with a catechol moiety,
features that correspond highly to a structural inhibitor
of xanthine oxidase, allopurinol. However, considering
the fact that allopurinol is a poor inhibitor of the NADH
oxidase activity of XDH from caprine milk (14.2% at 5 µM)

(Atmani et al., 2005), we decided to compare the structure
of calcelarioside kaempferol rutinoside and esculin with
DPI (Figure 4).
The striking structural characteristic of DPI is its
symmetry and the presence of a catechol moiety, the latter
being shared by the three most active compounds. Both
calcelarioside and esculin also have a glucosyl moiety in
common. This study was preceded by a previous report
demonstrating that esculin was a moderate inhibitor of
xanthine oxidase in vitro (Chang and Chiang, 1995), in
contrast to its high bioactivity against the NADH oxidase
of XDH demonstrated in this study, which confirms again
the different sites of inhibition of the two forms of XOR.
Therapeutic strategy against hyperuricemia is
mediated through the inhibition of XOR by allopurinol
or related drugs. Although they greatly reduce uric acid
production, these molecules are highly toxic. Therefore,
the discovery of safe, novel, and natural lead molecules
that perform the same functions would give hope for
patients with hyperuricemia. In the present report, an in
vivo experiment was conducted to tackle the disparity
issue between in vitro and in vivo results. The latter (Tables
6 and 7), which depicted the levels of uric acid, NADH
oxidase, and XDH inhibitory activities of the extracts in
normal and hyperuricemic mice, respectively, as well as
DPI, were shown to possess potent hypouricemic effects
in both cases. In fact, intraperitoneal injection of OP
elevated the mean levels of serum uric acid. This is due to
the inhibitory effect exerted by oxonate on uricase, which
converts uric acid to allantoin.
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Figure 4. Structure of calcelarioside (A), esculin (B), kaempferol rutinoside (C), and DPI (D).
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On the other hand, LFA, BFA, DPI, and esculin reduced
the serum uric acid levels in normal and hyperuricemic
mice, which ascertains their hypouricemic potential.
Esculin may be responsible for the hypouricemic effect
of bark by upregulating the expressions of renal organic
anion transporter 1 (mOAT1) and organic cation and
carnitine transporters (mOCT1-2 and mOCTN1-2), as
explained by Li et al. (2011).
The inhibition of liver XDH activity in hyperuricemic
mice by LFA and BFA is in accordance with their equal
performance in reducing uric acid levels, as reported
above.
In a previous study (Zhu et al., 2004), rutin has
shown a similar inhibitory potency on XDH activity in
hyperuricemic mice while DPI (10 mg kg-1) had the same
impact on normal and hyperuricemic mice.
Esculin was found to possess a good hypouricemic
potential in rodents, not related to its xanthine oxidase
inhibitory activity and only when administered
intraperitoneally, indicating that intestinal absorption
decreases its availability (Kong et al., 2002; Li et al., 2011).
Our results corroborate the decrease in biodisponibility
of esculin in vivo as the reduction in NADH oxidase
was diminished (54.36%) (Table 6) compared to in vitro
findings reported above (86.42%) (Table 1). The good
inhibitory impact of extracts, rutin, and esculin on the

NADH oxidase activity of XDH (59.73 and 68.27%,
respectively) (Table 7) rather than xanthine oxidase may
justify their hypouricemic effect.
In conclusion, phenolic compounds are well known
antioxidants that attract curiosity for their possible
therapeutic use against various disorders and ROSmediated diseases. The high potency of leaf and bark
extracts of F. angustifolia against the NADH oxidase
activity of xanthine dehydrogenase both in vitro and in vivo
provides strong evidence for the use of this plant to fight
antiinflammatory disorders, particularly gouty arthritis.
Reputed for their large array of biological activities, the
identified active constituents of F. angustifolia (kaempferol
rutinoside, esculin, and calcelarioside) represent a
beneficial therapeutic tool and may well become good
candidates for exploitation in the pharmacological
industry.
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